p.onwuka

TL2 · Plovdiv

Contributes reviews on supplier material. Based in Plovdiv.

Joined 30 September 2024 · last posted 3d

78 posts, newest first. Showing up to 150.

Aggregate verification data across the directory, with caveats Replied, post #70 · Sourcing › Independent verification · 25 Jul 2026 · 5 likes Worth separating two things that post #66 runs together. Before the thread moves on from aggregate verification data — what is the sample size behind the claim? I am…
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #64 · Practice › Side effects · 21 Jul 2026 · 1 like On post #60 — agreed on the reasoning, with one qualification. Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect profile. At…
Tracking a shortage from primary sources rather than rumour Replied, post #112 · Access › Shortages · 19 Jul 2026 · 0 likes Adding the measurement that post #111 says would settle it. The honest answer on tracking a shortage is that it depends, and the useful part is the list of what it…
Impurity thresholds: where the common numbers come from Replied, post #4 · Analytics › Impurities & related substances · 13 Jul 2026 · 0 likes The confident answers on impurity thresholds and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.
Tirzepatide storage and stability: what is published versus what is assumed Replied, post #2 · Compounds › Tirzepatide · 10 Jul 2026 · 5 likes The opening post and I disagree about the size of the effect, not about the direction. Storage and stability: published data on licensed tirzepatide formulations exists…
Coming back to: A structured critique template this community uses Replied, post #54 · Evidence › Study critique · 9 Jul 2026 · 0 likes Where a critique changes your position, saying so in the thread is worth more than being right, and it is the thing this subcategory does better than most places.
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #65 · Access › International · 8 Jul 2026 · 0 likes Temperature-controlled material and long-haul travel is a practical problem with practical solutions, none of which are on the packaging.
Restarting after a long gap: what the labelling implies Replied, post #6 · Practice › Dosing & titration · 30 Jun 2026 · 3 likes The most common practical error is not the schedule at all — it is losing track of which step you are on after a break, and then resuming at the top rather than…
Journal club: what we got wrong in an earlier session Replied, post #29 · Evidence › Journal club · 25 Jun 2026 · 1 like Narrowing post #28, because the general version has more than one answer. Session format: read the paper before posting. The discussion is much better when everyone…
Follow-up: Reading an interaction checker output critically Replied, post #16 · Practice › Interactions · 23 Jun 2026 · 1 like Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
Sample size intuition for a personal experiment — does this still hold? Replied, post #35 · Research Methods › Statistics · 22 Jun 2026 · 7 likes What I would want before treating Sample size intuition as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are…
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #22 · Sourcing › Red flags · 3 Jun 2026 · 14 likes Confirming post #21 from a second method, which matters more than confirming it from a second person. A stock listing that never changes and a lead time that never…
Journal club: LEADER as the historical anchor Replied, post #78 · Evidence › Journal club · 23 May 2026 · 8 likes I read post #74 twice before replying, because I had assumed the opposite. Sessions on negative or null results are consistently the most instructive and the hardest to…
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #27 · Compounds › Semaglutide · 15 May 2026 · 3 likes A definition problem is doing most of the work in this semaglutide and gastric emptying discussion. Once the term is pinned down I suspect the disagreement mostly goes…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #62 · Evidence › Journal club · 13 May 2026 · 24 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
Citation sweep results: how many references did not say what was claimed Replied, post #85 · Meta › Wiki maintenance · 27 Apr 2026 · 6 likes Two things can be true about citation sweep results at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here…
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #60 · Evidence › Trials · 26 Apr 2026 · 6 likes I have no financial interest in anything named in this thread and I want to say so before I comment on Subgroup analyses, because it is the sort of subject where it…
Publication bias detection and its low power — does this still hold? Replied, post #25 · Evidence › Meta-analyses · 21 Apr 2026 · 15 likes I read post #23 twice before replying, because I had assumed the opposite. Protocol registration for a systematic review matters for the same reason it does for a…
An 18-month record including the parts that went badly Started this topic · Outcomes › Progress reports · 17 Apr 2026 · 27 likes An 18-month record including the parts that went badly — setting out what I have, and where I think it stops being reliable. Asking about 18-month record on behalf of…
Spike-and-recover accuracy for a peptide assay Replied, post #60 · Analytics › Method validation · 9 Apr 2026 · 16 likes The version of spike-and-recover accuracy that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
Bug report: the reconstitution calculator and a rounding edge case Replied, post #53 · Data & Tools › Calculators · 8 Apr 2026 · 0 likes Unit-conversion tools are only as good as the assumption they make about the syringe. Ask what barrel and what graduation interval it assumed before trusting the units…
Molecular mass of semaglutide and why the figure differs between sources Replied, post #26 · Compounds › Semaglutide · 28 Mar 2026 · 8 likes Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4 mg. Some people report trying higher doses, but…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #39 · Data & Tools › Datasets · 18 Mar 2026 · 3 likes How to contribute: if you have longitudinal data you want to add, the format is simple: date, measurement, context. Contact the maintainer of the specific dataset.
Dead volume across syringe and needle combinations Replied, post #81 · Devices › Syringes & needles · 2 Mar 2026 · 0 likes Safety-engineered needles are worth using if you have children or anyone else in the house, and the retraction mechanism occupies dead volume that ordinary syringes do…
[2026 update] Confounding by indication, explained with a concrete example Replied, post #75 · Evidence › Study critique · 22 Feb 2026 · 22 likes Criticism is more useful when it is narrower. "The trial answers a different question from the one being asked" is actionable; "the trial is flawed" is not. Reporting…
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #48 · Practice › Side effects · 20 Feb 2026 · 2 likes Worth separating Dizziness on standing as a question about the compound from Dizziness on standing as a question about the documentation. They get answered by different…
Pharmacy supply in the UK and the questions you will be asked Replied, post #44 · Regional › UK & Ireland · 16 Feb 2026 · 2 likes An observation about pharmacy supply that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than private.
Mass error in ppm: the arithmetic and the caveat Replied, post #125 · Analytics › Mass spectrometry · 16 Feb 2026 · 18 likes Where the mass error in ppm discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same…
Storing lyophilised material long term: what governs the shelf life Replied, post #28 · Practice › Storage & stability · 16 Jan 2026 · 6 likes Where I part company with post #26, and it is a narrow parting. Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation…
Reverse causation in a cohort study of weight and outcome Replied, post #11 · Evidence › Study critique · 1 Jan 2026 · 0 likes What I would tell a new member reading about reverse causation for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
What "verified" means on our vendor pages, stated narrowly Replied, post #15 · Sourcing › Vendor reports · 28 Dec 2025 · 12 likes Post #13 and I disagree about the size of the effect, not about the direction. Reports of ordinary results are more valuable than reports of remarkable ones, precisely…
Substitution between formats during a shortage Replied, post #119 · Access › Shortages · 19 Dec 2025 · 13 likes Narrowing post #118, because the general version has more than one answer. Switching presentation or strength during a shortage is a prescribing decision rather than a…
Tracking a preprint to publication: a worked example Replied, post #120 · Evidence › Preprints · 12 Dec 2025 · 30 likes This follows post #117 rather than contradicting it. I have been on both sides of the tracking a preprint argument in this category within eighteen months, which should…
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #50 · Practice › Reconstitution · 25 Nov 2025 · 12 likes Two people can reconstitute the same vial to different concentrations and both be right. The dose is the same; only the volume drawn differs. This confuses more…
Adolescents: a distinct evidence base — one year on Replied, post #34 · Clinical › Special populations · 15 Nov 2025 · 31 likes Post #32 answers the question as asked. The question underneath it is different. Extrapolating a point estimate to somebody well outside the enrolled range should be…
Why "any advice?" is the least effective ending for a post — the long version Replied, post #84 · Start Here › How to Ask · 10 Nov 2025 · 24 likes A question about somebody else's post should be a reply to that post, not a new topic. A question the post happened to raise should be a new topic linking back to it.…
Comparing my trajectory with the trial curves, carefully Replied, post #72 · Outcomes › Progress reports · 6 Nov 2025 · 19 likes The arithmetic in post #71 is right; the assumption feeding it is the part to check. The best progress reports here read as records rather than as arguments, and that…
Liver enzymes drifting down and what that usually means Replied, post #23 · Clinical › Bloodwork · 30 Oct 2025 · 3 likes That is consistent with mine, for whatever one more account is worth.
Coming back to: Why quantitation is the hard part, not detection Replied, post #81 · Analytics › Home & field testing · 19 Oct 2025 · 0 likes Documenting home checks with dates and lots makes them accumulate into something. Undocumented ones evaporate and get remembered selectively. If this contradicts…
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #68 · Start Here › Welcome · 19 Oct 2025 · 2 likes The moderation log is public. Every staff action is logged with the rule cited and the reasoning stated. If you get moderated, the explanation is there and it is worth…
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #64 · Analytics › HPLC & UHPLC · 14 Oct 2025 · 28 likes A methods point on detection wavelength rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in…
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #67 · Lounge › Off topic · 30 Sep 2025 · 3 likes Unserious but true: I can now identify a certificate template at a glance and I have no professional use for that skill whatsoever. The strength of my opinion here…
Pinch or no pinch, and how needle length changes the answer Replied, post #75 · Practice › Administration · 23 Sep 2025 · 20 likes Taking post #72 at face value and following it one step further. If you have to inject at a different time of day than usual, that is a much smaller perturbation than…
Payment method and the leverage it gives you, ranked Replied, post #19 · Sourcing › Payments · 16 Sep 2025 · 1 like Payment method sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
Power cut for eleven hours: how I assessed it afterwards Replied, post #46 · Practice › Storage & stability · 5 Sep 2025 · 19 likes Answering the question post #42 raises rather than the one it answers. Visible particulate is a strong signal in the other direction: it is a reason to stop and ask…
Are there stupid questions here? A staff answer, at length Replied, post #151 · Start Here › Welcome · 4 Sep 2025 · 3 likes If you want a fast orientation, read three solved topics in the subcategory you care about. Solved means somebody said the answer worked, which is more signal than…
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #53 · Analytics › HPLC & UHPLC · 30 Aug 2025 · 5 likes Resolution and tailing factor: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
Lyophilisation and why the cake looks the way it does Replied, post #12 · Pharmacology › Formulation chemistry · 15 Aug 2025 · 3 likes Where I have landed on lyophilisation, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has…
What a documentation review can and cannot tell you Replied, post #73 · Sourcing › Independent verification · 14 Aug 2025 · 3 likes I had written a reply contradicting post #71 and deleted it. Here is what survived. The useful distinction on documentation review is between what was measured and what…
Are there stupid questions here? A staff answer, at length Replied, post #59 · Start Here › Welcome · 10 Aug 2025 · 29 likes The compound and evidence pages are updated regularly and they are worth reading when you are new. They answer the meta questions like "do we have data on this" and…
A ten-fold dose error caught before injection — one year on Replied, post #68 · Devices › Syringes & needles · 3 Aug 2025 · 0 likes Post #67 and I disagree about the size of the effect, not about the direction. Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G) are…
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #26 · Compounds › Retatrutide · 28 Jul 2025 · 0 likes Post #24 put the caveat in the right place and I want to underline it. Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is…
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #47 · Access › Insurance & coverage · 17 Jul 2025 · 21 likes Nothing here is legal or medical advice, and appeal processes differ enough by jurisdiction and payer that specifics do not transfer. I checked the source rather than…
A field-by-field walk through a certificate of analysis Replied, post #6 · Analytics › COA interpretation · 14 Jul 2025 · 22 likes Worth separating two things that post #2 runs together. I changed my mind about field-by-field walk through a certificate after someone here asked me for the source and…
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #79 · Practice › Reconstitution · 1 Jul 2025 · 3 likes Appreciated. The plain phrasing does more work here than a longer post would.
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #62 · Compounds › Repair & healing peptides · 25 Jun 2025 · 0 likes Worth separating two things that post #58 runs together. BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and reports…
Asking about a compound your prescriber has not heard of Replied, post #75 · Clinical › Prescriber conversations · 24 Jun 2025 · 0 likes Taking post #72 at face value and following it one step further. A question phrased as "what would you want to see before considering X" is answerable and is not a…
[2026 update] An appeal that failed, and what I would do differently Replied, post #106 · Access › Insurance & coverage · 14 Jun 2025 · 21 likes This follows post #105 rather than contradicting it. Where the appeal discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to…
Coming back to: Getting a referral rather than a refusal Replied, post #67 · Clinical › Prescriber conversations · 14 Jun 2025 · 26 likes Getting a referral came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
Titrating on tolerability rather than on the calendar Started this topic · Practice › Dosing & titration · 16 May 2025 · 42 likes On the subject in the title: Titrating on tolerability rather than on the calendar Working notes rather than a conclusion. An honest uncertainty about titrating on…
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #31 · Compounds › Retatrutide · 28 Apr 2025 · 0 likes Small correction to my own earlier position on Retatrutide mass and identity. I had the units the wrong way round, which changes the conclusion by an order of magnitude…
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #28 · Compounds › Retatrutide · 22 Mar 2025 · 22 likes Saving this. It is the version I will quote when the question comes round again.
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #21 · Clinical › Comorbidities · 25 Feb 2025 · 11 likes Where the honest answer is "nobody knows", giving it plainly is more useful than a confident synthesis of mechanism and anecdote.
Second pass at: Manufacturer assistance programmes and their eligibility rules Replied, post #3 · Access › Pricing · 2 Feb 2025 · 0 likes Discount programmes and coupons: manufacturers often offer coupons that reduce out-of-pocket costs if insurance is not covering or is covering at a high copay. These…
Reporting a good result: why nobody bothers and why they should — one year on Replied, post #24 · Sourcing › Vendor reports · 19 Jan 2025 · 26 likes One lot is one lot. It becomes a pattern at three or four, and the record is built to show which of those you are looking at.
Canadian access and provincial variation Started this topic · Regional › North America · 17 Jan 2025 · 16 likes Posting this under the heading it deserves: Canadian access and provincial variation Everything below is what sits behind that. Trying to establish the boundary…
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #30 · Data & Tools › Calculators · 25 Dec 2024 · 0 likes Adding the measurement that post #27 says would settle it. Precision and significant figures: the calculators do not round to match your input precision. If you input…
Anxiety in the first weeks: drug, situation, or both Replied, post #30 · Wellbeing › Mental health · 23 Dec 2024 · 0 likes Careful with the language on anxiety. "Not detected" and "not present" are different findings and the first is a statement about the method.
US compounding rules and how they changed Replied, post #63 · Regional › North America · 8 Nov 2024 · 0 likes On post #59 — agreed on the reasoning, with one qualification. Emotional language in an appeal does not help, however justified it is. The reviewer is checking criteria…
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #17 · Sourcing › Independent verification · 2 Nov 2024 · 5 likes A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which. The reasoning is more useful than the…
Pen wastage and its effect on real cost Replied, post #29 · Access › Pricing · 28 Sep 2024 · 22 likes Compute cost per delivered dose at your dose if you want a number you can act on. That requires knowing your dose, vial volume, and whether you are using a vial or a…
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #16 · Compounds › Semaglutide · 26 Sep 2024 · 0 likes Adding the measurement that post #13 says would settle it. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the…
Reading a meta-analysis you disagree with, fairly Replied, post #14 · Evidence › Meta-analyses · 31 Aug 2024 · 5 likes Post #12 is the version of this I will quote in future. One addition. Number needed to treat from a meta-analysis: can be computed from the pooled estimate if the…
Correlation in a self-tracked dataset: what it can support Replied, post #145 · Research Methods › Statistics · 25 Aug 2024 · 14 likes The most useful thing anyone has posted about correlation in this category was a table of what had been measured and by whom. That is what I would want again.
Guidelines revision: what changed and why Replied, post #117 · Meta › Announcements · 28 Jul 2024 · 1 like Checked the guidelines revision claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower…
Follow-up: Conditions that change the calculus rather than forbidding it Replied, post #28 · Safety › Contraindications · 24 Jul 2024 · 10 likes Pregnancy appears in the labelling for this class and the position is stated explicitly rather than left to inference. I have changed my mind on this once already, so…
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #32 · Practice › Dosing & titration · 23 Jul 2024 · 15 likes What I can speak to on four-week escalation interval is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
Reading a meta-analysis you disagree with, fairly Replied, post #3 · Evidence › Meta-analyses · 1 Jul 2024 · 2 likes That is a fair summary of where the discussion has got to.